China Plan To Exempt More Devices From Trials To Save Time, Costs
This article was originally published in PharmAsia News
Executive Summary
China's Food and Drug Administration is inviting feedback on a new batch of medical devices that it intends to exempt from having to undergo local clinical trials. The agency's proposal, if adopted, would make it much easier and less costly for companies that want to place these devices on the Chinese market.